Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer
Diogo Almeida-Rios(Instituto Português de Oncologia Francisco Gentil), Cármen Jerónimo(Universidade do Porto)
Cited by 67
Related Papers
Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests
|Cells|2023|95
Epigenetic modulators as therapeutic targets in prostate cancer
|Clinical Epigenetics|2016|90
Anti-neoplastic properties of hydralazine in prostate cancer
|Oncotarget|2014|63
Improved recovery of urinary small extracellular vesicles by differential ultracentrifugation
|Scientific Reports|2024|23